| |
|
|
|
Pluristem Therapeutics Inc.  
|
|
1.1 0.02 (0.02%) |
11-21 10:17 |
|
Open: |
1.08 |
Pre close: |
1.08 |
Target:
|
1.35
|
|
High: |
1.1 |
Low: |
1.07 |
Resistance:
|
1.16
1.22
|
|
Volume: |
8,452 |
Market Cap: |
127M |
Support:
|
1.05
0.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.09
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
1.14 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
1.25 |
Stochastic Oscillator |
%K(14,3):
|
20.83 |
|
MA(250): |
1.33 |
%D(3): |
25.00 |
|
Average Volume(K) |
3-Month: |
21939
|
52-Week |
High:
|
1.65 |
|
10-Days: |
18731 |
Low: |
1.05 |
|
RSI |
RSI(14):
|
30.02 |
Change(%): |
-30.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.160 |
Return on Equity (ttm) |
-120.0 |
Shares Out. (M) |
115.80 |
|
EPS Est. Current Year |
-0.350 |
Return on Assets (ttm) |
-89.0 |
Shares Float (M) |
101.94 |
|
EPS Est. Next Year |
-0.340 |
PEG Ratio |
0.00 |
% Held by Insiders |
12.50 |
|
EPS Est. Next Quarter |
-0.090 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
7.30 |
|
Forward EPS |
-0.350 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
5.920 |
EBITDA (p.s.) |
-0.069 |
P/E |
-6.75 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.18 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-24.70 |
P/S |
0.00 |
|
Operating Margin |
-65298.15 |
Levered Free Cash Flow
(M) |
-11.87 |
P/CF |
-5.06 |
|
|
|
|
|
|
